Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics. The Company's four premier brands include Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services. Its portfolio of products includes technologies for mass spectrometry, elemental analysis, molecular spectroscopy, sample preparation, informatics, purity chemistry production, protein analysis, Ribonucleic acid (RNA)-interference techniques, immunodiagnos. Thermo Fisher Scientific Inc. is headquartered in Waltham, Massachusetts.
Industry sector: Medical
Sector classification: Measuring & controlling devices, not elsewhere classified
Deep Learning based analysis and prediction model for Thermo Fisher Scientific Inc (TMO) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Oct. 22, 2015.
Market data for TMO model training are being downloaded from the
Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for TMO.
Model is being retrained on a daily basis.
|% Held by Insiders||0.49%|
|% Held by Institutions||87.20%|
|EPS (last reported FY)||$9.49|
|EPS (last reported Q)||$2.50|
|EPS, estimated (last reported Q)||$2.42|
|Total revenues||$21 B|
|Net income||$2 B|